Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation

References

• Abe Y, Kuroda Y, Kuboki N, Matsushita M, Yokoyama N, Kojima N. (2008). Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. J. Biochem., 144:563–570.
   Google Scholar
• Allen TM, Cullis PR. (2004). Drug delivery systems: entering the mainstream. Science, 303:1818–1822.
   PubMed Web of Science ®Google Scholar
• Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta, 1066:29–36.
   PubMed Web of Science ®Google Scholar
• Alving CR, Swartz Jr. GM. (1991). Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. Crit. Rev. Immunol. 10:441–53.
   PubMed Web of Science ®Google Scholar
• Arora A, Nair MG, Strasburg GM. (1998). Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic. Biol. Med., 24:1355–63.
   PubMed Web of Science ®Google Scholar
• Batzri S, Korn ED.(1973). Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta, 298:1015–9.
   Google Scholar
• Bradley DV, Wong K, Serrano K, Chonn A, Devine D. (1994). Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta, 1191:43–51.
   Google Scholar
• Carmo VA, De Oliveira MC, Reis EC, Guimarães TM, Vilela JM, Andrade MS, Michalick MS, Cardoso VN. (2008). Physicochemical characterization and study of in vitro interactions of pH-sensitive liposomes with the complement system. J. Liposome Res., 18:59–70.
   PubMed Web of Science ®Google Scholar
• Chonn A, Cullis PR, Devine DV. (1991). The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol., 146: 4234–41.
   PubMed Web of Science ®Google Scholar
• Chonn A, Semple SC, Cullis PR. (1992). Association of blood protein with large unilamellar liposomes in vivo: Relation to circulation lifetimes. J. Biol. Chem., 267:18759–18765.
   PubMed Web of Science ®Google Scholar
• Cimanga K, De Bruyne T, Lasure A, van Poel B, Pieters L, Vanden Berghe D, Vlietinck A, Kambu K, Tona L. (1995). In vitro anticomplementary activity of constituents from Morinda morindoides. J. Nat. Prod., 58:372–8.
   PubMed Web of Science ®Google Scholar
• Clarke MHG, Freeman T. (1968). Quantitative immunoelectrophoresis of human serum proteins. Clin. Sci., 35:403–13.
   PubMed Web of Science ®Google Scholar
• Cullis PR, Chonn A, Semple SC. (1998). Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev., 32:3–17.
   PubMed Web of Science ®Google Scholar
• Devine DV, Wong K, Serrano K, Chonn A, Cullis PR. (1994). Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta, 1191: 43–51.
   PubMed Web of Science ®Google Scholar
• Harashima H, Huong TM, Ishida T, Manabe Y, Matsuo H, Kiwada H. (1996). Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharm. Res., 13:1704–9.
   PubMed Web of Science ®Google Scholar
• Harrison RA, Lachmann PJ. (1986). Complement technology. In: Weir DM, ed. Handbook of Experimental Immunology. Oxford: Blackwell Scientific Publications, pp. 39.1–39.49.
   Google Scholar
• Haxby JA, Gotze O, Muller-Eberhard HJ, Kinsky SC. (1969). Release of trapped marker from liposomes by the action of purified complement components. Proc. Natl. Acad. Sci. USA, 64:290–295.
   PubMed Web of Science ®Google Scholar
• Hoffmann LG, Mayer MM. (1977). Immune hemolysis and complement fixation. In: Williams CA, Chase MW eds. Methods in Immunology and Immunochemistry. New York: Academic Press, pp. 140.
   Google Scholar
• Humphries GM, McConnel HM. (1975). Antigen mobility in membranes and complement-mediated immune attack. Proc. Natl. Acad. Sci. USA, 72:2483–87.
   PubMed Web of Science ®Google Scholar
• Huong TM, Ishida T, Harashima H, Kiwada H. (2001). Species difference in correlation between in vivo/in vitro liposome-complement interactions. Biol. Pharm. Bull., 24:439–441.
   Google Scholar
• Ishida T, Harashima H, Kiwada H. (2001). Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors. Curr. Drug Metab., 2:397–409.
   PubMed Web of Science ®Google Scholar
• Ishida T, Harashima H, Kiwada H. (2002). Liposome clearance. Biosci. Rep., 22:197–224.
   PubMed Web of Science ®Google Scholar
• Ishida T, Kojima H, Harashima H, Kiwada H.(2000). Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship. Int. J. Pharm, 205:183–193.
   PubMed Web of Science ®Google Scholar
• Ishida T, Yasukawa K, Kojima H, Harashima H, Kiwada H. (2001). Effect of cholesterol content in activation of the classical versus alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes. Int. J. Pharm., 224:69–79.
   PubMed Web of Science ®Google Scholar
• Kinsky SC, Haxby JA, Zopf DA, Alving CR, Kinsky CB. (1969). Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten. Biochemistry, 8:4149–4158.
   PubMed Web of Science ®Google Scholar
• Landi-Librandi AP, de Oliveira CA, Caleiro Seixas Azzolini AE, Mariko Kabeya L, Del Ciampo JO, Lopes Badra Bentley MV, Lucisano-Valim YM. (2011). In vitro evaluation of the antioxidant activity of liposomal flavonols by the HRP-H2O2-luminol system. J Microencapsul., 28:258–67.
   PubMed Web of Science ®Google Scholar
• Lee SY, Min BS, Kim JH, Lee J, Kim CS, Kim YH, Lee HK. (2005). Flavonoids from the leaves of Litsea japonica and their anti-complement activity. Phytother. Res., 19:273–276.
   PubMed Web of Science ®Google Scholar
• Lian T, Ho R. Trends and development in liposome drug delivery systems. (2001). J. Pharm. Sci. 90:667–680.
   PubMed Web of Science ®Google Scholar
• Limasset B, Osajoo T, le Doucen C, Doré JC. (1999). Inhibition of chemiluminescence in human PMNs by monocyclic phenolic acids and flavonoids. Planta Med., 65:23–9.
   PubMed Web of Science ®Google Scholar
• Mandal AK, Das N. (2005). Sugar coated liposomal flavonoid: a unique formulation in combating carbon tetrachloride induced hepatic oxidative damage. J. Drug Target, 13:305–15.
   PubMed Web of Science ®Google Scholar
• Mandal AK, Das S, Mitra M, Chakrabarti RN, Chatterjee M, Das N. (2008). Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. J. Exp. Ther. Oncol., 7:123–33.
   PubMedGoogle Scholar
• Marjan J, Xie Z, Devine DV. (1994). Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta, 1192:35–44.
   PubMed Web of Science ®Google Scholar
• Middleton Jr E, Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52:673–751.
   PubMed Web of Science ®Google Scholar
• Min BS, Lee SY, Kim JH, Lee J, Kim TJ, Kim DH, Kim YH, Joung H, Lee HK, Nakamura N, Miyashiro H, Hattori M. (2003). Anti-complement activity of constituents from the stem-bark of Junglans mandshurica. Biol. Pharm. Biol., 26:1042–4.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating nanoparticles: Theory to practice. Pharmacol. Rev., 53:283–318.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC. (2001). Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm. Res., 18:1–8.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lip. Res., 42:463–478.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng S. (2010). Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine, 5: 1017–1019.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. (2009). Target nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine, 4:105–118.
   PubMed Web of Science ®Google Scholar
• Nagayasu A, Uchiyama K, Nishida T, Yamagiwa Y, Kawai Y, Kiwada H. (1996). Is control of distribution of lipososmes between tumors and bone marrow possible? Biochim. Biophys. Acta, 1278:29–34.
   PubMed Web of Science ®Google Scholar
• Newman SL, Mikus LK. (1985). Deposition of C3b and iC3b onto particulate activators of the human complement system. J. Exp. Med., 161:1414–31.
   Google Scholar
• Oldfield E, Chapman D. (1971). Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids. Biochem. Biophys. Res. Commun., 43:610–616.
   PubMed Web of Science ®Google Scholar
• Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, Fraga CG. (2005). Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Dev. Immunol., 12:19–25.
   PubMedGoogle Scholar
• Pangburn MK, Müller-Eberhard HJ. (1978). Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA, 75:2416–20.
   PubMedGoogle Scholar
• Pfrommer GST, Dickens SM, Wilson MA, Young BJ, Kozel TR. (1993). Accelerated Decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans Capsule. Infection and Immunity, 61:4360–66.
   PubMed Web of Science ®Google Scholar
• Pieroni A, Heimler D, Pieters L, van Poel B, Vlietinck AJ. (1996). In vitro anti-complementary activity of flavonoids from olive (Olea europea L.) leaves. Pharmazie, 51:765–8.
   PubMed Web of Science ®Google Scholar
• Poste G. (1983). Liposome targeting in vivo - problems and opportunities. Biol. Cell, 47:19–38.
   Web of Science ®Google Scholar
• Reid KBM. (1986) Activation and control of complement system. Essays Biochem., 22:27–68.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Das N. (2006). Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech. Ageing Dev., 127:391–397.
   PubMed Web of Science ®Google Scholar
• Senior JH. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carr. Syst., 3:123–193.
   PubMed Web of Science ®Google Scholar
• Sim RB, Dodds AW. (1997). The complement system: an introduction. In: Dodds AW, Sim RB, eds. Complement. A Practical Approach. New York: Oxford University Press Inc., pp. 1-18.
   Google Scholar
• Szebeni J, Wassef NM, Rudolph AS, Alving CR. (1995). Complement activation by liposome-encapsulated hemoglobin in vitro: The role of endotoxin contamination. Artif. Cells Blood Substit. Immobil. Biotechnol., 23:355–363.
   PubMed Web of Science ®Google Scholar
• Tan LA, Yu B, Sim FC, Kishore U, Sim RB. (2010). Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell., 1:1033–49.
   Google Scholar
• Torchilin VP, Papisov MI. (1994). Why do polyethylene glycol-coated liposomes circulate so long? Molecular mechanism of liposome steric protection with polyethylene glycol: role of polymer chain flexibility). J. Liposome Res., 4:725–39.
   Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceuticals carriers. Nat. Rev. Drug Discov. 4:145–160.
   PubMed Web of Science ®Google Scholar
• Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, Oteiza PI. (2003). Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic. Biol. Med., 34:84–92.
   PubMed Web of Science ®Google Scholar
• Vogt W, Von Zabern I, Damerau B, Hesse D, Lühmann B, Nolte R. (1985). Mechanisms of complement activation by crystalline cholesterol. Mol. Immunol., 22:101–6.
   Google Scholar
• Wassef NM, Swartz Jr GM, Alving CR, Kates M. (1990). Antibodies to liposomal phosphatidylcholine and phosphatidylsulfocholine. Biochem. Cell Biol. 68:54–8.
   PubMed Web of Science ®Google Scholar
• Woodle MC, Lasic DD. (1992). Sterically stabilized liposomes. Biochim. Biophys. Acta, 1113:171–199.
   PubMed Web of Science ®Google Scholar